We are live on ! Find out more
Rikoon Group

Rikoon Group Portfolio holdings

AUM $376M Turnover 9.58%
1-Year Est. Return 56.75%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+56.75%
3 Year Est. Return
+63.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$376M
AUM Growth
+$17.7M
Cap. Flow
+$2.29M
Cap. Flow %
0.61%
Top 10 Hldgs %
32.1%
Holding
240
New
17
Increased
96
Reduced
53
Closed
6
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
3.3 years

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$786K
2
NXPI icon
NXP Semiconductors
NXPI
+$320K
3
SBUX icon
Starbucks
SBUX
+$315K
4
MAS icon
Masco
MAS
+$291K
5
BP icon
BP
BP
+$289K

Top Sells

Rank Stock Value
1
BCE icon
BCE
BCE
+$627K
2
SYK icon
Stryker
SYK
+$444K
3
EMR icon
Emerson Electric
EMR
+$397K
4
GILD icon
Gilead Sciences
GILD
+$285K
5
JNJ icon
Johnson & Johnson
JNJ
+$278K

Sector Composition

Rank Sector Weight
1 Healthcare 18.87%
2 Miscellaneous 15.49%
3 Technology 14.15%
4 Industrials 10.51%
5 Consumer Staples 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KMB icon
76
Kimberly-Clark
KMB
$35.9B
$1.16M 0.31%
8,280
– –
2016 Q3
18 quarters
AVY icon
77
Avery Dennison
AVY
$13.8B
$1.16M 0.31%
6,299
– –
2016 Q4
17 quarters
AZN icon
78
AstraZeneca
AZN
$289B
$1.15M 0.31%
11,563
-350
-3% -$35.2K
2016 Q3
18 quarters
AMAT icon
79
Applied Materials
AMAT
$310B
$1.14M 0.3%
8,550
– –
2017 Q1
16 quarters
UNH icon
80
UnitedHealth
UNH
$365B
$1.14M 0.3%
3,066
-85
-3% -$29.5K
2018 Q1
12 quarters
CVS icon
81
CVS Health
CVS
$115B
$1.11M 0.29%
14,712
+68
+0.5% +$4.95K
2016 Q3
18 quarters
PM icon
82
Philip Morris
PM
$325B
$1.04M 0.28%
11,580
– –
2016 Q4
17 quarters
QCLN icon
83
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$475M
$1.04M 0.28%
15,082
+378
+3% +$29K
2018 Q2
11 quarters
GSK icon
84
GSK
GSK
$99.2B
$1.03M 0.27%
22,723
– –
2016 Q3
18 quarters
MAIN icon
85
Main Street Capital
MAIN
$5.17B
$1.02M 0.27%
26,193
-3,173
-11% -$111K
2016 Q4
17 quarters
VIG icon
86
Vanguard Dividend Appreciation ETF
VIG
$116B
$1.01M 0.27%
6,854
+1,014
+17% +$144K
2018 Q1
12 quarters
CGNX icon
87
Cognex
CGNX
$9.45B
$996K 0.27%
12,000
– –
2016 Q4
17 quarters
VT icon
88
Vanguard Total World Stock ETF
VT
$80.5B
$996K 0.27%
10,242
+3
+0% +$288
2017 Q3
14 quarters
AVGO icon
89
Broadcom
AVGO
$1.56T
$990K 0.26%
21,350
+750
+4% +$34.7K
2020 Q2
3 quarters
RTX icon
90
RTX Corp
RTX
$270B
$967K 0.26%
12,514
+35
+0.3% +$2.55K
2020 Q2
3 quarters
SYK icon
91
Stryker
SYK
$112B
$950K 0.25%
3,890
-1,850
-32% -$444K
2016 Q4
17 quarters
VEU icon
92
Vanguard FTSE All-World ex-US ETF
VEU
$66.2B
$948K 0.25%
15,626
-138
-0.9% -$8.39K
2016 Q4
17 quarters
LH icon
93
Labcorp
LH
$29.3B
$941K 0.25%
4,293
+763
+22% +$153K
2019 Q2
7 quarters
PHG icon
94
Philips
PHG
$26.3B
$936K 0.25%
20,236
– –
2018 Q1
12 quarters
BX icon
95
Blackstone
BX
$94.6B
$931K 0.25%
12,492
+1
+0% +$69
2019 Q3
6 quarters
FINX icon
96
Global X FinTech ETF
FINX
$152M
$925K 0.25%
20,970
+5,225
+33% +$246K
2020 Q4
1 quarter
CSCO icon
97
Cisco
CSCO
$412B
$922K 0.25%
17,837
+308
+2% +$14.5K
2017 Q3
14 quarters
SBUX icon
98
Starbucks
SBUX
$118B
$909K 0.24%
8,320
+3,000
+56% +$315K
2018 Q1
12 quarters
ROKU icon
99
Roku
ROKU
$23B
$888K 0.24%
2,725
– –
2019 Q1
8 quarters
ARKW icon
100
ARK Next Generation Technology ETF
ARKW
$1.72B
$875K 0.23%
5,933
-107
-2% -$17.3K
2018 Q2
11 quarters

Similar funds

Rikoon Group's Q1 2021 Portfolio in Review

As of Q1 2021, Rikoon Group held 240 positions worth $376M, up 4.9% from $358M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rikoon Group's Q1 2021 filing shows 17 new, 96 increased, 53 reduced and 6 closed positions. Its largest new stake was Eaton: 6,095 shares worth $843K. The largest sale was BCE, an estimated $627K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Miscellaneous and Technology.

  • Rikoon Group's largest Q1 2021 buy was Eaton: 6,095 shares worth $843K.
  • Rikoon Group added most to Starbucks in Q1 2021, an estimated $315K increase.
  • Rikoon Group's biggest Q1 2021 reduction was BCE, cutting an estimated $627K.
  • Rikoon Group fully exited Gilead Sciences in Q1 2021, selling an estimated $285K.
  • Rikoon Group's ten largest holdings make up 32% of its $376M portfolio in Q1 2021.
  • Rikoon Group opened 17 new positions and closed 6 in Q1 2021.
  • Rikoon Group's portfolio value rose 4.9% quarter-over-quarter to $376M.

Based on Rikoon Group's 13F filing for Q1 2021, filed 14 May 2021.